7/8/05 News Brief: Supplier and Media People Moves

SUPPLIERS
Advanced Health Media has promoted Marianne Racioppi to operations manager. Prior to her current position, Racioppi was a senior project supervisor.

Advanced Medical Marketing Communications has named Kim Levy as vice president, account services. Prior to Advanced, Levy developed her own business, providing medical education and marketing consulting services and was formerly managing director for Adair Greene Healthcare Communications.

The Patient Marketing Group has named Michele Demak Epstein to serve as associate vice president, program design leader. She was the manager of program development at Hastings Healthcare Group, where she applied principles of behavioral science and health psychology.

PDI, Inc., a sales and marketing company, has promoted Christopher Tama to executive vice president and general manager, diversified teams. Tama was executive vice president and general manager of PDI Pharmaceutical products group.

MEDIA
The Jobson Medical Group has named Maura Griffin as editor of Women's Health in Primary Care. Griffin has served as editor on a number of primary care publications including The Female Patient, Modern Medicine, Menopause Management, OBG Management, Physician Assistant, and The Nurse Practitioner.

You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.